Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
12.19
-0.55 (-4.32%)
At close: Oct 29, 2025, 4:00 PM EDT
12.01
-0.18 (-1.48%)
After-hours: Oct 29, 2025, 7:55 PM EDT
Ginkgo Bioworks Holdings Revenue
Ginkgo Bioworks Holdings had revenue of $49.60M in the quarter ending June 30, 2025, a decrease of -11.75%. This brings the company's revenue in the last twelve months to $230.82M, up 25.21% year-over-year. In the year 2024, Ginkgo Bioworks Holdings had annual revenue of $227.04M, down -9.71%.
Revenue (ttm)
$230.82M
Revenue Growth
+25.21%
P/S Ratio
2.84
Revenue / Employee
$276,757
Employees
834
Market Cap
675.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 227.04M | -24.41M | -9.71% |
| Dec 31, 2023 | 251.46M | -226.25M | -47.36% |
| Dec 31, 2022 | 477.71M | 163.87M | 52.21% |
| Dec 31, 2021 | 313.84M | 237.18M | 309.40% |
| Dec 31, 2020 | 76.66M | 22.47M | 41.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
DNA News
- 6 days ago - Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program - PRNewsWire
- 7 weeks ago - Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium - Business Wire
- 2 months ago - Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions - PRNewsWire
- 2 months ago - Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry - PRNewsWire
- 2 months ago - Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth - PRNewsWire
- 2 months ago - Ginkgo Bioworks: Sell The Recent Rally - Seeking Alpha
- 2 months ago - Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Ginkgo Bioworks Reports Second Quarter 2025 Financial Results - PRNewsWire